Related Experiment Video
Updated: Jun 3, 2026
A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
Published on: February 27, 2019
Computational approaches for the design of peptides with anti-breast cancer properties
1Department of Chemistry and Physics, College of Science and Technology, Armstrong Atlantic State University, 11935 Abercorn Street, Savannah, GA 31419, USA. george.shields@armstrong.edu
Background:
Breast cancer is the most common cancer among women. Tamoxifen is the preferred drug for estrogen receptor-positive breast cancer treatment, yet many of these cancers are intrinsically resistant to tamoxifen or acquire resistance during treatment. Therefore, scientists are searching for breast cancer drugs that have different molecular targets.
Methodology:
Recently, a computational approach was used to successfully design peptides that are new lead compounds against breast cancer. We used replica exchange molecular dynamics to predict the structure and dynamics of active peptides, leading to the discovery of smaller bioactive peptides.
Conclusions:
These analogs inhibit estrogen-dependent cell growth in a mouse uterine growth assay, a test showing reliable correlation with human breast cancer inhibition. We outline the computational methods that were tried and used along with the experimental information that led to the successful completion of this research.
Insights
Scientists designed new peptide drugs for breast cancer treatment, offering an alternative to tamoxifen. These compounds show promise in inhibiting estrogen-dependent cancer growth, addressing drug resistance.
Area of Science:
- Oncology
- Computational Chemistry
- Drug Discovery
Background:
- Breast cancer is the most prevalent cancer in women.
- Tamoxifen resistance is a significant challenge in treating estrogen receptor-positive breast cancer.
- Novel therapeutic targets are needed for breast cancer treatment.
Purpose of the Study:
- To computationally design novel peptide-based lead compounds against breast cancer.
- To identify smaller, bioactive peptides with potential therapeutic applications.
- To address the challenge of tamoxifen resistance in breast cancer treatment.
Main Methods:
- Utilized a computational approach for peptide design.
- Employed replica exchange molecular dynamics to predict peptide structure and dynamics.
- Validated peptide efficacy using a mouse uterine growth assay.
Main Results:
- Successfully designed novel peptide lead compounds against breast cancer.
- Discovered smaller bioactive peptides through structural and dynamic predictions.
- Identified peptide analogs that inhibit estrogen-dependent cell growth.
Conclusions:
- The designed peptide analogs demonstrate efficacy in a relevant preclinical model.
- Computational methods combined with experimental validation led to successful drug discovery.
- These findings offer a promising new avenue for breast cancer therapy, particularly for tamoxifen-resistant cases.
More Related Videos
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
05:08Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
Published on: July 8, 2025
